New Kit Reveals Biological Roles and Dynamics of RNA-Protein Binding

RNA-binding protein immunoprecipitation advances studies of post-transcriptional gene regulation

Billerica, Massachusetts—August 5, 2009—Millipore Corporation (NYSE: MIL), a leading provider of technologies, tools and services for the global life science industry, today launched its new Magna RIP™ RNA-binding protein immunoprecipitation (RIP) kit, which is the first to provide a complete solution for the entire RIP workflow. With this kit, any researcher, even those inexperienced in RNA purification, can investigate the dynamics of ribonucleoprotein assembly as it occurs inside the cell.

Cells respond to stimuli by altering gene expression, and RNA-protein complexes drive almost all processes regulating gene expression at the post-transcriptional level, including splicing, nuclear export, mRNA stability, and translation. Therefore, understanding gene regulation depends on characterizing the changes in RNA binding in these various processes. Traditionally, RNA-protein interactions have been identified by screening libraries in yeast, bacteria, or by in vitro selection, all confounded by system limitations, biases, or artifacts. In contrast, data obtained from RIP show increased biological relevance, enabling researchers to achieve their goals more quickly.

 “We know that an RNA binding protein can bind different RNA targets depending on physiological context,” said Dr. Robert Nakamura, CEO of Advanced Genetic Systems, a biotechnology company validating RNA-protein complexes as therapeutic targets. “By isolating intact complexes from cells, we can identify the specific interactions between molecules, and potentially disrupt these interactions for therapeutic benefits.”

The RIP application can be viewed as the RNA-based analog of the more well-known ChIP application (chromatin immunoprecipitation), which identifies DNA targets of DNA-binding proteins. RIP involves immunoprecipitating proteins, then purifying and characterizing their associated RNAs. Because of the heightened awareness of RNA’s role in gene regulation, the development of higher throughput RNA identification methods, the validation of more antibodies against RNA-binding proteins, and now the availability of RIP kits, the pace of RIP-based research is expected to accelerate.

Millipore’s Magna RIP kit contains all the reagents needed to quantitatively isolate RNA-protein complexes with full-length, intact RNAs. Reagents include protein A/G magnetic beads optimized to bind nucleic acid-protein immune complexes, RNAse inhibitors, RNAse-free buffers, and positive and negative controls. Millipore also offers specially designed RIPAb+ validated antibody/primer sets, RIP-validated antibodies, and over 80 other antibodies recognizing RBPs.

Download High Resolution Image
Click here to download high resolution image

Additional Resources
RNA-binding protein immunoprecipitation learning center

---

About Millipore
Millipore (NYSE: MIL) is a Life Science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the world’s challenging human health issues. From research to development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals. Millipore Corporation is an S&P 500 company with 5,900 employees worldwide. For more information, please contact Millipore Tech Service at 1-800-548-7853 or 951-676-8080 or visitwww.millipore.com.

ADVANCING LIFE SCIENCE TOGETHER^TM
Research. Development. Production.

Millipore Media Contact
Greg Hoff, Media Relations Manager, Bioscience Division
978-762-5170 // greg_hoff@millipore.com


Millipore is a registered trademark and the “M” logo, ADVANCING LIFE SCIENCE TOGETHER and Magna RIP are trademarks of Millipore Corporation.